Primers for your Patient
Skin Spectrum Summit
March 23, 2020
By Dhiren Mahiban
Following prior studies using microneedle patches for vaccination, researchers attempted to advance the technology with the objective of treating skin conditions by rubbing STAR particles on the skin.
March 9, 2020
Researchers at UC San Diego identified how Staphylococcus aureus and Staphylococcus epidermidis can act as a catalyst for skin inflammation and barrier damage in mouse models.
March 2, 2020
The study found that between 2015 and 2018, 3.94% of patch-tested people were allergic to propolis, compared to 2.35% of people patch-tested between 2007 to 2010—an increase of 68%.
February 24, 2020
By Dhiren Mahiban
The Barrier Enhancement for Eczema Prevention study aimed to determine whether use of moisturizers had any impact on preventing the development of eczema in newborns.
February 10, 2020
Researchers from the Centenary Institute at The University of Sydney in Australia have developed a new therapeutic strategy that could help patients with advanced-stage melanoma.
February 3, 2020
A GW study found dermatologists are unprepared to respond to biological disasters and that the specialty would benefit from formal preparedness training.
January 20, 2020
Immunoglobulin E, an antibody that usually helps defend the skin against harmful substances or infections, may promote tumor growth during chronic tissue inflammation.
January 6, 2020
Allergic reactions in the skin can be caused by many different chemical compounds found in creams, cosmetics, and other topical consumer products.
December 16, 2019
For patients prone to acne flare-ups, the key is to select cosmetics that do not cause acne and establish a skincare routine that works for the individual’s skin type.
December 9, 2019
While treatments conducted by professionals can be beneficial to the patient, products designed to be used at home can have negative outcomes.
Older Posts >
Atopic Dermatitis (49)
Skin Cancer (113)
Skin Spectrum Summit (37)
Patient care (5)
Clinical Practice (0)